MedTrace Logo

Cystic Fibrosis and Fit-to-Fly

NCT03843723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2023-12-20

No results posted yet for this study

Summary

Due to the hypobaric hypoxia during air travel, some patients with Cystic Fibrosis (CF) need supplemental oxygen during air travel.

The study aims to evaluate if adding exercise desaturation to the pre-flight evaluation will help predict requirements for in-flight supplemental oxygen.

Conditions

Interventions

OTHER

Pre-flight evaluation

All the participants receive the interventions as part of their routine medical care during their annual visit for CF follow-up. Oxygen saturation are measured by pulse oximetry. Exercise testing is performed by 6MWT and CPET. Pre-flight evaluation is performed by HAST.

Sponsors & Collaborators

  • The Norwegian Resouce Centre for Cystic Fibrosis

    collaborator UNKNOWN

  • Norwegian National Adivisory Unit on Rare Disorders

    collaborator UNKNOWN

  • University Hospital, Akershus

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Aina Akerø, MD PhD · Oslo University Hospital, Dept. of Pulm. Med.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03843723 on ClinicalTrials.gov